- Details
- Description
Packaging Size:
30 tablets*
Strength:
80 mg
Composition:
Osimertinib 80 mg
Treatment:
EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)
Form:
Tablet
Brand:
Osimert
Quantity Unit:
Tablets
Manufacturer:
Everest Pharmaceuticals Ltd.
Osimert 80 mg (Osimertinib INN) is a targeted anticancer medicine used primarily for the treatment of EGFR-mutated non-small cell lung cancer (NSCLC). It is an EGFR tyrosine kinase inhibitor (TKI) that works by blocking abnormal EGFR signaling, helping to slow or stop the growth and spread of cancer cells. Osimertinib may be used in certain patients with EGFR mutations for early-stage, locally advanced, or metastatic NSCLC, depending on the clinical setting. It is an oral prescription medicine and should be used under the supervision of an oncology specialist.
